GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeyondSpring Inc (NAS:BYSI) » Definitions » YoY EBITDA Growth

BYSI (BeyondSpring) YoY EBITDA Growth : 19.51% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BeyondSpring YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. BeyondSpring's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 19.51%.

BeyondSpring's EBITDA per Share for the six months ended in Dec. 2024 was $-0.03.


BeyondSpring YoY EBITDA Growth Historical Data

The historical data trend for BeyondSpring's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeyondSpring YoY EBITDA Growth Chart

BeyondSpring Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.65 22.14 44.46 58.71 43.80

BeyondSpring Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.54 31.89 90.12 45.09 19.51

BeyondSpring YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

BeyondSpring's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.213--0.379)/ | -0.379 |
=43.80 %

BeyondSpring's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.033--0.041)/ | -0.041 |
=19.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BeyondSpring YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of BeyondSpring's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


BeyondSpring Business Description

Traded in Other Exchanges
N/A
Address
100 Campus Drive, West Side, 4th Floor, Suite 410, Florham Park, New Jersey, NJ, USA, 07932
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.